Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Clinical characteristics of colitis induced by taxane-based chemotherapy.

Chen E, Abu-Sbeih H, Thirumurthi S, Mallepally N, Khurana S, Wei D, Altan M, Morris VK, Tan D, Barcenas CH, Wang Y.

Ann Gastroenterol. 2020 Jan-Feb;33(1):59-67. doi: 10.20524/aog.2019.0431. Epub 2019 Nov 21.

2.

Correction to: Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis.

Abu-Sbeih H, Herrera LN, Tang T, Altan M, Chaftari AM, Okhuysen PC, Jenq RR, Wang Y.

J Immunother Cancer. 2019 Dec 17;7(1):352. doi: 10.1186/s40425-019-0832-5.

3.

Neutropenic Enterocolitis: Clinical Features and Outcomes.

Abu-Sbeih H, Ali FS, Chen E, Mallepally N, Luo W, Lu Y, Foo WC, Qiao W, Okhuysen PC, Adachi JA, Hachem RY, Altan M, Jenq RR, Wang Y.

Dis Colon Rectum. 2019 Dec 13. doi: 10.1097/DCR.0000000000001548. [Epub ahead of print]

PMID:
31842164
4.

Serum sphingosine-1-phosphate levels in bladder pain syndrome/interstitial cystitis patients: could it help in diagnosis?

Asi T, Asci A, Altan M, Gudeloglu A, Ergen A.

World J Urol. 2019 Dec 2. doi: 10.1007/s00345-019-03045-6. [Epub ahead of print]

PMID:
31792578
5.

Phase II Trial of Concurrent Atezolizumab With Chemoradiation for Unresectable NSCLC.

Lin SH, Lin Y, Yao L, Kalhor N, Carter BW, Altan M, Blumenschein G, Byers LA, Fossella F, Gibbons DL, Kurie JM, Lu C, Simon G, Skoulidis F, Chang JY, Jeter MD, Liao Z, Gomez DR, O'Reilly M, Papadimitrakopoulou V, Thall P, Heymach JV, Tsao AS.

J Thorac Oncol. 2019 Nov 25. pii: S1556-0864(19)33659-7. doi: 10.1016/j.jtho.2019.10.024. [Epub ahead of print]

PMID:
31778797
6.

Phase I Trial of Pembrolizumab and Radiation Therapy after Induction Chemotherapy for Extensive-Stage Small Cell Lung Cancer.

Welsh JW, Heymach JV, Chen D, Verma V, Cushman TR, Hess KR, Shroff G, Tang C, Skoulidis F, Jeter M, Menon H, Nguyen QN, Chang JY, Altan M, Papadimitrakopoulou VA, Simon GR, Raju U, Byers L, Glisson B.

J Thorac Oncol. 2019 Oct 9. pii: S1556-0864(19)33525-7. doi: 10.1016/j.jtho.2019.10.001. [Epub ahead of print]

PMID:
31605794
7.

Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis.

Abu-Sbeih H, Herrera LN, Tang T, Altan M, Chaftari AP, Okhuysen PC, Jenq RR, Wang Y.

J Immunother Cancer. 2019 Sep 5;7(1):242. doi: 10.1186/s40425-019-0714-x. Erratum in: J Immunother Cancer. 2019 Dec 17;7(1):352.

8.

Influence of low-dose radiation on abscopal responses in patients receiving high-dose radiation and immunotherapy.

Menon H, Chen D, Ramapriyan R, Verma V, Barsoumian HB, Cushman TR, Younes AI, Cortez MA, Erasmus JJ, de Groot P, Carter BW, Hong DS, Glitza IC, Ferrarotto R, Altan M, Diab A, Chun SG, Heymach JV, Tang C, Nguyen QN, Welsh JW.

J Immunother Cancer. 2019 Sep 4;7(1):237. doi: 10.1186/s40425-019-0718-6.

9.

Outcomes to first-line pembrolizumab in patients with non-small-cell lung cancer and very high PD-L1 expression.

Aguilar EJ, Ricciuti B, Gainor JF, Kehl KL, Kravets S, Dahlberg S, Nishino M, Sholl LM, Adeni A, Subegdjo S, Khosrowjerdi S, Peterson RM, Digumarthy S, Liu C, Sauter J, Rizvi H, Arbour KC, Carter BW, Heymach JV, Altan M, Hellmann MD, Awad MM.

Ann Oncol. 2019 Oct 1;30(10):1653-1659. doi: 10.1093/annonc/mdz288.

PMID:
31435660
10.

An Unusual Cause of the Transient Osteoporosis of the Femoral Head: Essential Thrombocytosis.

Altan M, Bayram S, Salduz A, Özmen E, Ekinci M.

J Orthop Case Rep. 2019 Jan-Feb;9(1):41-44. doi: 10.13107/jocr.2250-0685.1300.

11.

Three-Dimensional Nano-Morphology of Carbon Nanotube/Epoxy Filled Poly(methyl methacrylate) Microcapsules.

Icduygu MG, Asilturk M, Yalcinkaya MA, Hamidi YK, Altan MC.

Materials (Basel). 2019 Apr 29;12(9). pii: E1387. doi: 10.3390/ma12091387.

12.

Fabrication of High Quality, Large Wet Lay-Up/Vacuum Bag Laminates by Sliding a Magnetic Tool.

Sussmann M, Amirkhosravi M, Pishvar M, Altan MC.

Polymers (Basel). 2018 Sep 5;10(9). pii: E992. doi: 10.3390/polym10090992.

13.

Early introduction of selective immunosuppressive therapy associated with favorable clinical outcomes in patients with immune checkpoint inhibitor-induced colitis.

Abu-Sbeih H, Ali FS, Wang X, Mallepally N, Chen E, Altan M, Bresalier RS, Charabaty A, Dadu R, Jazaeri A, Lashner B, Wang Y.

J Immunother Cancer. 2019 Apr 2;7(1):93. doi: 10.1186/s40425-019-0577-1.

14.

Immune Checkpoint Inhibitor-Associated Pericarditis.

Altan M, Toki MI, Gettinger SN, Carvajal-Hausdorf DE, Zugazagoitia J, Sinard JH, Herbst RS, Rimm DL.

J Thorac Oncol. 2019 Jun;14(6):1102-1108. doi: 10.1016/j.jtho.2019.02.026. Epub 2019 Mar 7.

PMID:
30851443
15.

Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC).

Carvajal-Hausdorf D, Altan M, Velcheti V, Gettinger SN, Herbst RS, Rimm DL, Schalper KA.

J Immunother Cancer. 2019 Mar 8;7(1):65. doi: 10.1186/s40425-019-0540-1.

16.

Role of Radiation Therapy in Modulation of the Tumor Stroma and Microenvironment.

Menon H, Ramapriyan R, Cushman TR, Verma V, Kim HH, Schoenhals JE, Atalar C, Selek U, Chun SG, Chang JY, Barsoumian HB, Nguyen QN, Altan M, Cortez MA, Hahn SM, Welsh JW.

Front Immunol. 2019 Feb 15;10:193. doi: 10.3389/fimmu.2019.00193. eCollection 2019. Review.

17.

Clinical characteristics and outcomes of immune checkpoint inhibitor-induced pancreatic injury.

Abu-Sbeih H, Tang T, Lu Y, Thirumurthi S, Altan M, Jazaeri AA, Dadu R, Coronel E, Wang Y.

J Immunother Cancer. 2019 Feb 6;7(1):31. doi: 10.1186/s40425-019-0502-7.

18.

Association of B7-H4, PD-L1, and tumor infiltrating lymphocytes with outcomes in breast cancer.

Altan M, Kidwell KM, Pelekanou V, Carvajal-Hausdorf DE, Schalper KA, Toki MI, Thomas DG, Sabel MS, Hayes DF, Rimm DL.

NPJ Breast Cancer. 2018 Dec 10;4:40. doi: 10.1038/s41523-018-0095-1. eCollection 2018.

19.

Palliative Posterior Instrumentation versus Corpectomy with Cage Reconstruction Treatment for Thoracolumbar Pathological Fracture.

Bayram S, Akgül T, Altan M, Pehlivanoğlu T, Kaya Ö, Özdemir MA, Şar C.

Asian Spine J. 2019 Apr;13(2):318-324. doi: 10.31616/asj.2018.0153. Epub 2018 Nov 29.

20.

Surgical outcome of patients with vesicoureteral reflux from a single institution in reference to the ESPU guidelines: a retrospective analysis.

Çitamak B, Bozaci AC, Altan M, Haberal HB, Kahraman O, Ceylan T, Doğan HS, Tekgül S.

J Pediatr Urol. 2019 Feb;15(1):73.e1-73.e6. doi: 10.1016/j.jpurol.2018.10.017. Epub 2018 Oct 27.

PMID:
30472078
21.

Silk as a Natural Reinforcement: Processing and Properties of Silk/Epoxy Composite Laminates.

Hamidi YK, Yalcinkaya MA, Guloglu GE, Pishvar M, Amirkhosravi M, Altan MC.

Materials (Basel). 2018 Oct 30;11(11). pii: E2135. doi: 10.3390/ma11112135.

22.

Impact of Food and Drug Administration Approval of Vismodegib on Prevalence of Orbital Exenteration as a Necessary Surgical Treatment for Locally Advanced Periocular Basal Cell Carcinoma.

Sagiv O, Ding S, Ferrarotto R, Glisson B, Altan M, Johnson F, Elamin Y, Thakar SD, Nagarajan P, Esmaeli B.

Ophthalmic Plast Reconstr Surg. 2019 Jul/Aug;35(4):350-353. doi: 10.1097/IOP.0000000000001251.

PMID:
30365473
23.

Immune Marker Profiling and Programmed Death Ligand 1 Expression Across NSCLC Mutations.

Toki MI, Mani N, Smithy JW, Liu Y, Altan M, Wasserman B, Tuktamyshov R, Schalper K, Syrigos KN, Rimm DL.

J Thorac Oncol. 2018 Dec;13(12):1884-1896. doi: 10.1016/j.jtho.2018.09.012. Epub 2018 Sep 26.

24.

Ocular preservation with neoadjuvant vismodegib in patients with locally advanced periocular basal cell carcinoma.

Sagiv O, Nagarajan P, Ferrarotto R, Kandl TJ, Thakar SD, Glisson BS, Altan M, Esmaeli B.

Br J Ophthalmol. 2019 Jun;103(6):775-780. doi: 10.1136/bjophthalmol-2018-312277. Epub 2018 Jul 18.

25.
26.

Safety of Programmed Death-1 Pathway Inhibitors Among Patients With Non-Small-Cell Lung Cancer and Preexisting Autoimmune Disorders.

Leonardi GC, Gainor JF, Altan M, Kravets S, Dahlberg SE, Gedmintas L, Azimi R, Rizvi H, Riess JW, Hellmann MD, Awad MM.

J Clin Oncol. 2018 Jul 1;36(19):1905-1912. doi: 10.1200/JCO.2017.77.0305. Epub 2018 May 10.

27.

Mechanisms and clinical activity of an EGFR and HER2 exon 20-selective kinase inhibitor in non-small cell lung cancer.

Robichaux JP, Elamin YY, Tan Z, Carter BW, Zhang S, Liu S, Li S, Chen T, Poteete A, Estrada-Bernal A, Le AT, Truini A, Nilsson MB, Sun H, Roarty E, Goldberg SB, Brahmer JR, Altan M, Lu C, Papadimitrakopoulou V, Politi K, Doebele RC, Wong KK, Heymach JV.

Nat Med. 2018 May;24(5):638-646. doi: 10.1038/s41591-018-0007-9. Epub 2018 Apr 23.

28.

An assessment of neuronal calcium sensor-1 and response to neoadjuvant chemotherapy in breast cancer patients.

Moore LM, Wilkinson R, Altan M, Toki M, Carvajal-Hausdorf DE, McGuire J, Ehrlich BE, Rimm DL.

NPJ Breast Cancer. 2018 Mar 12;4:6. doi: 10.1038/s41523-018-0057-7. eCollection 2018.

29.

Positioning the Instillation of Contrast Cystography: Does It Provide Any Clinical Benefit?

Haberal HB, Çıtamak B, Altan M, Bozacı AC, Ceylan T, Doğan HS, Tekgül S.

Urology. 2018 Feb;112:164-168. doi: 10.1016/j.urology.2017.10.034. Epub 2017 Nov 15.

PMID:
29154987
30.

Erratum to: Effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes and PD-L1 expression in breast cancer and its clinical significance.

Pelekanou V, Carvajal-Hausdorf DE, Altan M, Wasserman B, Carvajal-Hausdorf C, Wimberly H, Brown J, Lannin D, Pusztai L, Rimm DL.

Breast Cancer Res. 2017 Sep 25;19(1):109. doi: 10.1186/s13058-017-0898-2. No abstract available.

31.

Effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes and PD-L1 expression in breast cancer and its clinical significance.

Pelekanou V, Carvajal-Hausdorf DE, Altan M, Wasserman B, Carvajal-Hausdorf C, Wimberly H, Brown J, Lannin D, Pusztai L, Rimm DL.

Breast Cancer Res. 2017 Aug 7;19(1):91. doi: 10.1186/s13058-017-0884-8. Erratum in: Breast Cancer Res. 2017 Sep 25;19(1):109.

32.

A critical prognostic analysis of neutrophil-lymphocyte ratio for patients undergoing nephroureterectomy due to upper urinary tract urothelial carcinoma.

Altan M, Haberal HB, Akdoğan B, Özen H.

Int J Clin Oncol. 2017 Oct;22(5):964-971. doi: 10.1007/s10147-017-1150-x. Epub 2017 Jun 9.

PMID:
28600686
33.

B7-H3 Expression in NSCLC and Its Association with B7-H4, PD-L1 and Tumor-Infiltrating Lymphocytes.

Altan M, Pelekanou V, Schalper KA, Toki M, Gaule P, Syrigos K, Herbst RS, Rimm DL.

Clin Cancer Res. 2017 Sep 1;23(17):5202-5209. doi: 10.1158/1078-0432.CCR-16-3107. Epub 2017 May 24.

34.

Adjustable Perineal Male Sling for the Treatment of Urinary Incontinence: Long-term Results.

Altan M, Asi T, Bilen CY, Ergen A.

Urology. 2017 Aug;106:216-220. doi: 10.1016/j.urology.2017.04.030. Epub 2017 May 2.

PMID:
28476682
35.

Predicting the stone composition of children preoperatively by Hounsfield unit detection on non-contrast computed tomography.

Altan M, Çitamak B, Bozaci AC, Güneş A, Doğan HS, Haliloğlu M, Tekgül S.

J Pediatr Urol. 2017 Oct;13(5):505.e1-505.e6. doi: 10.1016/j.jpurol.2017.03.013. Epub 2017 Mar 31.

PMID:
28427913
36.

Assessment of P wave duration and P wave dispersion in high level football referees.

Yucesir I, Sahin Yildiz B, Coskun O, Yakal S, Bayraktar B, Metin G, Altan M, Yildiz M.

J Sports Med Phys Fitness. 2017 Jan-Feb;57(1-2):162. doi: 10.23736/S0022-4707.16.05983-1. No abstract available.

PMID:
28124873
37.

Is There Any Difference Between Questionnaires on Pediatric Lower Urinary Tract Dysfunction?

Altan M, Çitamak B, Bozaci AC, Mammadov E, Doğan HS, Tekgül S.

Urology. 2017 May;103:204-208. doi: 10.1016/j.urology.2016.12.055. Epub 2017 Jan 9.

PMID:
28082122
38.

EGFR-GRB2 Protein Colocalization Is a Prognostic Factor Unrelated to Overall EGFR Expression or EGFR Mutation in Lung Adenocarcinoma.

Toki MI, Carvajal-Hausdorf DE, Altan M, McLaughlin J, Henick B, Schalper KA, Syrigos KN, Rimm DL.

J Thorac Oncol. 2016 Nov;11(11):1901-1911. doi: 10.1016/j.jtho.2016.06.025. Epub 2016 Jul 20.

39.

Tuberculosis tenosynovitis with multiple rice bodies of the flexor tendons in the wrist: A case report.

Bayram S, Erşen A, Altan M, Durmaz H.

Int J Surg Case Rep. 2016;27:129-132. doi: 10.1016/j.ijscr.2016.08.021. Epub 2016 Aug 28.

40.

Differential Expression and Significance of PD-L1, IDO-1, and B7-H4 in Human Lung Cancer.

Schalper KA, Carvajal-Hausdorf D, McLaughlin J, Altan M, Velcheti V, Gaule P, Sanmamed MF, Chen L, Herbst RS, Rimm DL.

Clin Cancer Res. 2017 Jan 15;23(2):370-378. doi: 10.1158/1078-0432.CCR-16-0150. Epub 2016 Jul 20.

41.

Invasive Squamous Carcinoma and Adenocarcinoma of an Unreconstructed Exstrophic Bladder with HPV Infection.

Altan M, Çıtamak B, Haberal HB, Söğütdelen E, Bozaci AC, Baydar DE, Doğan HS, Tekgül S.

Curr Urol. 2016 May;9(2):109-12. doi: 10.1159/000442863. Epub 2016 May 20.

42.

The nomogram conundrum: a demonstration of why a prostate cancer risk model in Turkish men underestimates prostate cancer risk in the USA.

Kara O, Elshafei A, Nyame YA, Akdogan B, Malkoc E, Gao T, Altan M, Citamak B, Mammadov E, Dursun F, Greene DJ, Senkul T, Ates F, Ozen H, Stephen Jones J.

Int Urol Nephrol. 2016 Oct;48(10):1623-9. doi: 10.1007/s11255-016-1328-6. Epub 2016 May 28.

PMID:
27236298
43.

Percutaneous Nephrolithotomy in Children: 17 Years of Experience.

Çıtamak B, Altan M, Bozacı AC, Koni A, Doğan HS, Bilen CY, Şahin A, Tekgül S.

J Urol. 2016 Apr;195(4 Pt 1):1082-7. doi: 10.1016/j.juro.2015.11.070. Epub 2015 Dec 9.

PMID:
26682755
44.

Management of Small Cell Lung Cancer: Progress and Updates.

Altan M, Chiang AC.

Cancer J. 2015 Sep-Oct;21(5):425-33. doi: 10.1097/PPO.0000000000000148. Review.

PMID:
26389768
45.

Bentamapimod (JNK Inhibitor AS602801) Induces Regression of Endometriotic Lesions in Animal Models.

Palmer SS, Altan M, Denis D, Tos EG, Gotteland JP, Osteen KG, Bruner-Tran KL, Nataraja SG.

Reprod Sci. 2016 Jan;23(1):11-23. doi: 10.1177/1933719115600553. Epub 2015 Sep 2.

46.

Effects of a regular exercise program on biochemical parameters of type 2 diabetes mellitus patients.

Dinçer Ş, Altan M, Terzioğlu D, Uslu E, Karşidağ K, Batu Ş, Metin G.

J Sports Med Phys Fitness. 2016 Nov;56(11):1384-1391. Epub 2015 Jul 15.

PMID:
26176617
47.

EGFR-directed antibodies increase the risk of severe infection in cancer patients.

Altan M, Burtness B.

BMC Med. 2015 Feb 20;13:37. doi: 10.1186/s12916-015-0276-9.

48.

A new nomogram for prediction of outcome of pediatric shock-wave lithotripsy.

Dogan HS, Altan M, Citamak B, Bozaci AC, Karabulut E, Tekgul S.

J Pediatr Urol. 2015 Apr;11(2):84.e1-6. doi: 10.1016/j.jpurol.2015.01.004. Epub 2015 Mar 5.

PMID:
25812469
49.

Factors affecting the success of endoscopic treatment of vesicoureteral reflux and comparison of two dextranomer based bulking agents: does bulking substance matter?

Dogan HS, Altan M, Citamak B, Bozaci AC, Koni A, Tekgul S.

J Pediatr Urol. 2015 Apr;11(2):90.e1-5. doi: 10.1016/j.jpurol.2014.12.009. Epub 2015 Mar 2.

PMID:
25791422
50.

Assessment of P wave duration and P wave dispersion in high level football referees.

Yucesir I, Sahin Yildiz B, Coskun O, Yakal S, Bayraktar B, Metin G, Altan M, Yildiz M.

J Sports Med Phys Fitness. 2016 Jan-Feb;56(1-2):120-4. Epub 2015 Feb 18.

PMID:
25692858

Supplemental Content

Support Center